US3574621A - Process for the development of photographic silver images in acid medium 1,4-diazine - Google Patents
Process for the development of photographic silver images in acid medium 1,4-diazine Download PDFInfo
- Publication number
- US3574621A US3574621A US718927A US3574621DA US3574621A US 3574621 A US3574621 A US 3574621A US 718927 A US718927 A US 718927A US 3574621D A US3574621D A US 3574621DA US 3574621 A US3574621 A US 3574621A
- Authority
- US
- United States
- Prior art keywords
- silver
- development
- solution
- reduction
- diazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229910052709 silver Inorganic materials 0.000 title abstract description 59
- 239000004332 silver Substances 0.000 title abstract description 58
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 title abstract description 46
- 238000011161 development Methods 0.000 title abstract description 45
- 238000000034 method Methods 0.000 title abstract description 44
- 230000008569 process Effects 0.000 title abstract description 38
- 239000002253 acid Substances 0.000 title abstract description 25
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 title description 8
- 230000009467 reduction Effects 0.000 abstract description 41
- 150000003216 pyrazines Chemical class 0.000 abstract description 7
- 150000002894 organic compounds Chemical class 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 53
- 230000018109 developmental process Effects 0.000 description 42
- 238000006722 reduction reaction Methods 0.000 description 40
- -1 silver halide Chemical class 0.000 description 31
- 239000000047 product Substances 0.000 description 25
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 25
- 239000002609 medium Substances 0.000 description 20
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 13
- 150000003378 silver Chemical class 0.000 description 13
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- 239000001117 sulphuric acid Substances 0.000 description 12
- 235000011149 sulphuric acid Nutrition 0.000 description 12
- 150000004891 diazines Chemical class 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 8
- 238000009792 diffusion process Methods 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 7
- 239000001828 Gelatine Substances 0.000 description 6
- 229920000159 gelatin Polymers 0.000 description 6
- 235000019322 gelatine Nutrition 0.000 description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 6
- ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 6
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- NLKINWOSVGBCSV-UHFFFAOYSA-N 3-phenyl-1,2-dihydroquinoxaline Chemical compound C1NC2=CC=CC=C2N=C1C1=CC=CC=C1 NLKINWOSVGBCSV-UHFFFAOYSA-N 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 239000003638 chemical reducing agent Substances 0.000 description 4
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 4
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 4
- XXKIXPWTFVBBJF-UHFFFAOYSA-N 1-(3-methylquinoxalin-2-yl)ethanone Chemical compound C1=CC=C2N=C(C)C(C(=O)C)=NC2=C1 XXKIXPWTFVBBJF-UHFFFAOYSA-N 0.000 description 3
- GGZHVNZHFYCSEV-UHFFFAOYSA-N 1-Phenyl-5-mercaptotetrazole Chemical compound SC1=NN=NN1C1=CC=CC=C1 GGZHVNZHFYCSEV-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 229910021645 metal ion Inorganic materials 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 235000011007 phosphoric acid Nutrition 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- ZIZMDHZLHJBNSQ-UHFFFAOYSA-N 1,2-dihydrophenazine Chemical compound C1=CC=C2N=C(C=CCC3)C3=NC2=C1 ZIZMDHZLHJBNSQ-UHFFFAOYSA-N 0.000 description 2
- PRJNKAPVRVTXEY-UHFFFAOYSA-N 1-(3-methyl-3,4-dihydroquinoxalin-2-yl)ethanone Chemical compound CC1NC2=CC=CC=C2N=C1C(C)=O PRJNKAPVRVTXEY-UHFFFAOYSA-N 0.000 description 2
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 2
- 239000006171 Britton–Robinson buffer Substances 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 2
- 229910021607 Silver chloride Inorganic materials 0.000 description 2
- 239000004133 Sodium thiosulphate Substances 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 125000005331 diazinyl group Chemical group N1=NC(=CC=C1)* 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 150000002988 phenazines Chemical class 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- IWZKICVEHNUQTL-UHFFFAOYSA-M potassium hydrogen phthalate Chemical compound [K+].OC(=O)C1=CC=CC=C1C([O-])=O IWZKICVEHNUQTL-UHFFFAOYSA-M 0.000 description 2
- 150000003252 quinoxalines Chemical class 0.000 description 2
- 238000011946 reduction process Methods 0.000 description 2
- ZUNKMNLKJXRCDM-UHFFFAOYSA-N silver bromoiodide Chemical compound [Ag].IBr ZUNKMNLKJXRCDM-UHFFFAOYSA-N 0.000 description 2
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000004383 yellowing Methods 0.000 description 2
- BKWQKVJYXODDAC-UHFFFAOYSA-N 1,2-dihydropyridazine Chemical compound N1NC=CC=C1 BKWQKVJYXODDAC-UHFFFAOYSA-N 0.000 description 1
- XXBQLHATYQHJQC-UHFFFAOYSA-N 1,2-dihydroquinoxaline Chemical compound C1=CC=C2N=CCNC2=C1 XXBQLHATYQHJQC-UHFFFAOYSA-N 0.000 description 1
- ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2 ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 0.000 description 1
- QWNCDHYYJATYOG-UHFFFAOYSA-N 2-phenylquinoxaline Chemical compound C1=CC=CC=C1C1=CN=C(C=CC=C2)C2=N1 QWNCDHYYJATYOG-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000035657 Abasia Diseases 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 229910004039 HBF4 Inorganic materials 0.000 description 1
- 229910021612 Silver iodide Inorganic materials 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- SJOOOZPMQAWAOP-UHFFFAOYSA-N [Ag].BrCl Chemical compound [Ag].BrCl SJOOOZPMQAWAOP-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- FSEXLNMNADBYJU-UHFFFAOYSA-N alpha-Phenylquinoline Natural products C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=N1 FSEXLNMNADBYJU-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVQLCTNNEUAWMS-UHFFFAOYSA-N barium oxide Chemical compound [Ba]=O QVQLCTNNEUAWMS-UHFFFAOYSA-N 0.000 description 1
- 229910001864 baryta Inorganic materials 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- OIPQUBBCOVJSNS-UHFFFAOYSA-L bromo(iodo)silver Chemical compound Br[Ag]I OIPQUBBCOVJSNS-UHFFFAOYSA-L 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- 150000001989 diazonium salts Chemical class 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- BYBCDPXQFQGGTR-UHFFFAOYSA-L disilver;bromide;iodide Chemical compound [Br-].[Ag+].[Ag+].[I-] BYBCDPXQFQGGTR-UHFFFAOYSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001362 electron spin resonance spectrum Methods 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 239000013081 microcrystal Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000002828 nitro derivatives Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 1
- 229940116357 potassium thiocyanate Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- NIPZZXUFJPQHNH-UHFFFAOYSA-N pyrazine-2-carboxylic acid Chemical compound OC(=O)C1=CN=CC=N1 NIPZZXUFJPQHNH-UHFFFAOYSA-N 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 231100000489 sensitizer Toxicity 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical compound [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C5/00—Photographic processes or agents therefor; Regeneration of such processing agents
- G03C5/26—Processes using silver-salt-containing photosensitive materials or agents therefor
- G03C5/29—Development processes or agents therefor
- G03C5/30—Developers
- G03C5/3028—Heterocyclic compounds
Definitions
- metal ions for example Fe, Ti or V are capable of reducing silver ions to silver.
- Such developers have however not attained any practical significance, since the normal potentials of these systems (for example Fe Fe are too positive and therefore the reduction comes to a stop even at low concentrations of oxidized metal ions (for example Fe). Whilst the redox potential can be lowered by adding suitable complex-forming agents, the action of the metal ion developers is generally weak, that is to say their sensitivity utilisation is low, and they are more of historical and theoretical significance.
- n denotes an integer and a and a each denotes a hydroxyl groups or a primary to tertiary amino group. More details about the developer substances may be found in the book by Mees, The Theory of the Photographic Process, 3rd edition, 1966, pages 278 to 311.
- This invention is based on the completely surprising observation that a large class of organic compounds is excellently suitable for the development of photographic silver images in an acid medium.
- the subject of this invention is accordingly a process for the development of photographic silver images from silver salts in which the silver is liberated from the silver salts in an acid medium in the presence of reduction products of 1,4-diazine compounds which have at most been reduced to the dihydro stage.
- diazine compounds are those which contain at least one ring of formula (III) N but which apart from this may be substituted at the ring carbon atoms as desired, especially also by further condensed ring systems.
- these compounds to be used as reducing agents must themselves be in a reduced state relative to the diazine.
- This state may be in equilibrium anywhere between the diazine and the dihydro stage and in a borderline case it is also possible, at least at the beginning of the development process, for practically the whole quantity of reducing agent to be present as dihydro compound.
- the reduction products of the diazines may occur as protonisation products. Accordingly, the monovalent or divalent reduction products of the 1,4-diazine compound are suitable for the development in accordance with the present process.
- the divalent reaction stages or dihydro compounds (IV) are mostly protonised in an acid medium, whilst the monovalent reaction stage represents a radical which in general is present in the protonised form up to high pH-values.
- R Substituent, for example -CH .R: Substituent, for example Details of such redox and protonisation processes are extensively explained in the book by W. M. Clark, Oxidation-Reduction Potentials of Organic Systems, 1960, Williams & Wilkins, Baltimore.
- the reducing agents for the reduction of the silver salts to the reduction medium in the form of the dihydro compounds, since the dihydro compounds can easily be manufactured from the corresponding diazines, for example by catalytic reduction, by reduction with suitable reducing agents for example Cr compounds or sodium dithionite, by electrolytic reduction or with the aid of electron exchangers.
- the dihydrodiazine compounds are directly obtainable by ring closure.
- the radical stage forms from the dihydro stage and the corresponding diazine at a certain equilibrium concentration, with the maximum concentration of radical depending on the difference of the two redox potentials E E
- the radical can be easily detected by electron spin resonance spectra.
- the present process may be carried out for example between the diazine and monohydro stage or between the monohydro and dihydro stage.
- reduction products of any desired compounds which contain the ring of Formula III at least once can be used in the present process, for example the monovalent or divalent reduction products of pyrazines, quinoxalines and phenazines, and/ or their protonisation products.
- R1 ⁇ N R3 (quinoxalines) phenyl residue or a heterocyclic residue
- R and R may be different or preferably identical with one another.
- the carbocyclic 6-membered rings of Formulae V, VI and VII formedby R and R together with two carbon atoms of the diazine ring may contain further substituents for example methyl or methoxy groups or halogen atoms or may preferably be free from such substituents.
- diazines whose reduction products of the type mentioned may be used in the present process are as follows:
- the present process is preferably carried out in aqueous medium which has been rendered acid with a suitable acid or a buffer mixture, advantageously to a pH-value of between 0 and 4.
- a suitable acid or a buffer mixture advantageously to a pH-value of between 0 and 4.
- the speed of development and the gradation may be varied within Wide limits as a function of the pH-value.
- acids and buffer substances the following may be mentioned: aliphatic, aromatic or heterocyclic monocarboxylic and dicarboxylic acids, which may also contain substitutents for example chlorine, bromine and iodine atoms, hydroxyl, nitro, amino or acylamino groups, and also aliphatic or aromatic sulphonic acids, phosphoric acids, ammonium ions for example NH or NH alkyl HSO4 HF/HCl, HBr, HCl-O4, H CO H3PO4, H2804, HSO3 S02,
- the developers are preferably employed in the form of aqueous solutions.
- the requisite reduction stage of the diazine compound may also be produced directly in the developing solution, for example by mixing the components, by electrolytic reduction of the diazine compound or may be produced in other ways from stable derivatives of the developer substances.
- the developers may also be caused to act on the silver salt by impregnating an absorbent strip with the solutions or by incorporating them in suspension or droplets of a high-boiling crystalloid solvent or in capsules of the light-sensitive layer or of an adjacent layer which can be broken open by pressure or change of pH, or by disposing them in containers which can be torn open between the layers of film packs for the diffusion transfer process.
- the temperature range for development may also be varied within wide limits.
- the developer solution may also contain reduction products of a mixture of two or more diazines of the type mentioned or other reducing or oxidising substances for setting up the desired redox equilibrium.
- a certain quantity of diazine may be added, particularly to a developer which has been freshly charged with a dihydrodiazine, in order to have the radical monohydrodiazine, which under certain circumstances is particularly desirable, already available at the beginning of the development.
- the developer solution may contain silver halide solvents for example bromide ions, thiocyanate ions or thiourea at a suitable concentration.
- Haze preventatives for example benzotriazole or phenylmercaptotetrazole may also be added.
- Hardeners for gelatine, toning substances for producing a bluish black silver image and surface-active substances for uniform wetting may also be added to the developer solution.
- the developer solutions to be used in accordance with the invention are suitable for the development of any desired silver halide emulsion, for example emulsions of silver chloride, silver bromide, silver chlorobromide or silver bromoiodide.
- the emulsions furthermore may contain in the usual layer-forming agents, preferably in gelatine, the usual additives for example sensitisers and surface-active substances and can be sensitive to the most diverse radiation of corpuscular and electromagnetic nature.
- Silver salts vaporised onto a substrate and free from binders may also be developed in accordance with the invention.
- development is here generally to be understood to mean the reduction of silver salts in layer materials, that is to say not only the selective reduction of silver halide crystals which have been exposed image- Wise, but also the reduction of silver salts in layers which have been exposed to diffuse light and the reduction of silver salts Which can be developed Without exposure to light, for example rehalogenated silver or silver salt with haze nuclei, which are present for example in chemically hazed emulsions.
- the second development in the reversal process, the physical development in the metal diazo process or the reduction of dissolved silver salts in the positive layer of the silver salt transfer process, Where silver salts are reduced in contact with colloidal metal or sulphide may be carried out according to the present reduction process.
- Mono-baths for the so-called stabilisation process may also be employed in accordance with the invention.
- the process is advantageous for surface development by direct positive methods which depend on the principle of a latent internal image; such methods are for example described in U.S.A. patent specifications Nos. 2,456,953 and 2,479,875 and in Dutch patent applications Nos. 66.05890 and 66.05891.
- the developer solutions of the invention are at the same time suitable for the reduction of azo dyestufis which are used as image dyestuffs in the silver colour bleaching process.
- suitable reduction conduitions it is possible, in a layer which in addition to silver halide simultaneously contains a reducible azo dyestulf, preferentally to reduce the silver halide in the exposed areas whilst the dyestuif is reduced in the unexposed areas. In this way a corrected dyestulf image is produced alongside the silver image.
- other reducible substances for example diazonium salts, nitro compounds or quinones can also be reduced imagewise in the unexposed areas.
- the first development may be carried out in ac cordance with the invention in an acid medium using the reducing 1,4-diazine compounds and the chromogenic development may be carried out according to known methods.
- Other novel effects may be achieved by combining layer colloids having different swelling and diffusion characteristics depending on the pH-value or by using filter cover layers which are only soluble in an alkaline medium, which after the acid first development still retain their optical effectiveness and are only dissolved off in a later process stage.
- EXAMPLE 3 2.60 g. of quinoxaline are dissolved in ml. of ethanol and 900 ml. of 0.1 N sulphuric acid. The solution is hydrogenated using palladium charcoal as catalyst until 0.02 mol of hydrogen has been taken up.
- the solution is also suitable for the development of other photographic materials containing silver halide, for example commercially available copying papers, enlargement papers, diapositive films and the like.
- EXAMPLE 4 0.01 mol of 2-methyl-3-acetylquinoxa1ine is dissolved in 500 ml. of dimethylformamide and hydrogenated with palladium charcoal as catalyst until 0.01 mol of hydrogen has been taken up. The palladium charcoal is filtered off and the filtrate is added to 500 ml. of 0.2 N sulphuric acid.
- Example 3 Thereafter a photographic negative film is exposed, developed and fixed as described in Example 3 and a similar result is obtained. Other photographic materials as mentioned in Example 3 may also be developed with this solution.
- EXAMPLE 5 0.01 mol of compound (45) is dissolved in 500 ml. of glacial acetic acid and hydrogenated using platinum oxide as the catalyst until 0.01 mol of hydrogen has been taken up. A photographic negative film is then exposed, developed and fixed exactly as described in Example 3. A similar result is obtained. Other photographic materials as mentioned in Example 3 may also be developed with this solution.
- EXAMPLE 6 EXAMPLE 7 The procedure of Example 6 is followed but a developing bath of the following composition is used: 4.0 g. of 2-methyl-3-acetyldihydroquinoxaline and 1,000 ml. of 0.1 N sulphuric acid.
- EXAMPLE 8 1 g. of potassium thiocyanate is dissolved in developer solution (a) described in Example 6, and 0.5 g. of potassium bromide is dissolved in developer solution (b).
- EXAMPLE 9 The developer solution (b) mentioned in Example 6 is manufactured from phenazine by reduction with sodium dithionite (E. Tom-arofl, Annales de Chimie 13, 124 [1956]).
- EXAMPLE 11 1,000 g. of a silver bromide-silver iodide emulsion consisting of 96 mol percent of AgBr and 4 mol percent of AgI and containing 35 g. of Ag are mixed with a solution of 35 g. of 3-phenyl-1,2-dihydroquinoxaline in acetone. The dihydroquinoxaline precipitates in a finely dispersed form. After adding the usual casting additives for example wetting agents and hardens the silver halide emulsion is applied to a transparent triacetate film substrate. Amount of silver applied: 4 g. Ag. mf
- the film manufactured in this way is exposed behind a grey wedge.
- the film is bathed for 5 minutes at 24 C. in a solution of 100 ml. of dimethylformamide in 900 ml. of 0.1 N sulphuric acid, briefly rinsed with water and then fixed in the usual manner. A negative image of the grey wedge used for the exposure is obtained.
- EXAMPLE 12 A solution of the following composition is prepared: 2.48 g. of reduced pyrazine-2-carboxylic acid (as in Example 1) 100 ml. of ethanol, 60 ml. of 100% acetic acid, 82 g. of anhydrous sodium acetate and 900 ml. of water.
- the pH-value of the bath is 4.7.
- EXAMPLE 13 An emulsion layer sensitised to red light and containing per 1 m? of layer support, 1.5 g. of silver in the form of silver bromo-iodide (96 mol percent of AgBr and 4 mol percent of Ag) and 0.2 g. of the bluish-green dyestufi of used and 200 mg. of phenylmercaptotetrazole are dissolved therein.
- the Britton-Robinson buffer solution consists of a solution which contains 0.04 M each of phosphoric acid, boric acid and acetic acid and which has been adjusted to the desired pH-value with 0.2 N sodium hydroxide solution.
- a commercially available photographic negative film is developed in the solution described in the first paragraph for 10 minutes at 24 C.
- the results are similar to those obtained when development is carried out according to Example 4, but the haze is somewhat greater.
- 3 g. of dihydrophenazine may be used in 100 ml. of ethanol and 900 ml. of buffer solution.
- the dihydrophenazine is is exposed to red light behind a grey wedge.
- the exposed layer is treated for 4 minutes at 20 C. in a solution (a) of the following composition: 6 g. of 2-methyl-3-acetyldihydroquinoxaline, 500 ml. of 0.1 M potassium hydrogen phthalate and 495 ml. of 0.1 N sulphuric acid (pH-value of the solution: 2.20)
- the exposed layer may also be treated with solution (b): 1 g. of 3-phenyl-1,2- dihydroquinoxaline, 1 g. of 2-methyl-3-acetylquinoxaline, 200 ml. of dimethylformamide, 300 ml. of 0.1 N potassium hydro-gen phthalate solution and 500 ml. of 0.1 N sulphuric acid (pH-value of the solution: 2.0 to 2.1
- the layer After a brief soaking the layer is treated for 5 minutes with a silver bleaching bath of the following composition: 25 g. of CuSO -5H O, 30 g. of KBr, ml. of 37% HCl and 1,000 m1. of water, and thereafter fixed with a thiosulphate solution in the usual manner. A bluish-green colour image of the grey wedge used for the exposure is then obtained which is negative relative to the original.
- a silver bleaching bath of the following composition: 25 g. of CuSO -5H O, 30 g. of KBr, ml. of 37% HCl and 1,000 m1. of water, and thereafter fixed with a thiosulphate solution in the usual manner.
- a bluish-green colour image of the grey wedge used for the exposure is then obtained which is negative relative to the original.
- EXAMPLE 14 35 g. of gelatine are dissolved in 500 ml. of water at 40 C. and to this solution are added 10 mg. of commercial colloid-silver dissolved in 20 ml. of water, 10 ml. of an alcoholic solution of 1-phenyl-5-mercaptotetrazole 15 (1%) and 3 m1. of formaldehyde solution (10%). The solution is applied in a thin layer to a baryta paper, dried and used as the image-receiving layer for producing an image according to the silver salt diffusion process.
- a text original is exposed onto a commercially available negative paper for the silver salt diffusion process, predominantly containing silver chloride.
- the exposed negative paper together with the receiving layer is passed through a roller development apparatus of the type used in the silver salt diffusion process, the development apparatus being filled with a developer of the following composition: 0.1 mol of 2-methyl-3-dihydroquinoxaline, 500 ml. of dimethylformamide, 500' ml. of 0.2 N sulphuric acid and 0.4 g. of thiourea.
- a process for the development of a photographic silver image from a silver salt which comprises liberating the silver from the silver salt in an acid medium in the presence of a reduction product of a 1,4-diazine compound which has at most been reduced to the dihydro stage.
- a process for the development of a photographic silver image from a silver salt as claimed in claim 1, which comprises liberating the silver from the silver salt in an acid medium in the presence of a reduction product of a diazine compound of the formula 16 in which n, p and q each denotes an integer having a value of at most 3, and r 6-p--q.
- a process for the development of a photographic silver image from a silver salt as claimed in claim 1, which comprises liberating the silver from a silver halide which is distributed in a photographic layer and is exposed image-wise by reduction in an acid medium having a pH-value of at most 4 in the presence of a reduction product of a 1,4-diazine compound which has at most been reduced to the dihydro stage.
- a process for the development of a photographic silver image from a silver salt which comprises liberating the silver from a silver halide which is distributed in a photographic layer and is exposed image-wise by reduction in an acid medium in the presence of a reduction product of a 1,4-diazine compound lying between the monohydro stage and the dihydro stage.
Landscapes
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH565567A CH484454A (de) | 1967-04-20 | 1967-04-20 | Verfahren zur Entwicklung photographischer Silberbilder |
Publications (1)
Publication Number | Publication Date |
---|---|
US3574621A true US3574621A (en) | 1971-04-13 |
Family
ID=4297206
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US718927A Expired - Lifetime US3574621A (en) | 1967-04-20 | 1968-04-04 | Process for the development of photographic silver images in acid medium 1,4-diazine |
Country Status (8)
Country | Link |
---|---|
US (1) | US3574621A (en:Method) |
AT (1) | AT285320B (en:Method) |
BE (1) | BE713975A (en:Method) |
CH (1) | CH484454A (en:Method) |
DE (1) | DE1772123C2 (en:Method) |
FR (1) | FR1565800A (en:Method) |
GB (1) | GB1183176A (en:Method) |
NL (1) | NL162488C (en:Method) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3718469A (en) * | 1969-10-17 | 1973-02-27 | Fuji Photo Film Co Ltd | Making of a photographic image |
US4172723A (en) * | 1977-07-20 | 1979-10-30 | De Luxe General, Incorporated | Auxiliary developer processing |
US4243745A (en) * | 1978-05-25 | 1981-01-06 | Ciba-Geigy Ag | Electrolytic production of active diazine species |
US4269928A (en) * | 1978-02-28 | 1981-05-26 | Ciba-Geigy Aktiengesellschaft | Process for the production of photographic images by dye diffusion transfer and photographic material suitable in this process |
US4420551A (en) * | 1983-01-31 | 1983-12-13 | Polaroid Corporation | Novel benzotriazine developers and photographic product and method |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7810745A (nl) * | 1977-10-28 | 1979-05-02 | Ciba Geigy | Werkwijze voor de vervaardiging van fotografische beelden. |
IT1106238B (it) * | 1977-10-28 | 1985-11-11 | Ciba Geigy Ag | Procedimento e materiale per produrre immagini fotofrafiche |
DE3721739A1 (de) * | 1987-07-01 | 1989-01-12 | Igor Groza | Digitalaufnahmekassette |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT236226B (de) * | 1961-01-20 | 1964-10-12 | Gevaert Photo Prod Nv | Verfahren zur Entwicklung einer belichteten photographischen Halogensilberemulsionsschicht |
-
1967
- 1967-04-20 CH CH565567A patent/CH484454A/de not_active IP Right Cessation
-
1968
- 1968-04-02 DE DE1772123A patent/DE1772123C2/de not_active Expired
- 1968-04-04 US US718927A patent/US3574621A/en not_active Expired - Lifetime
- 1968-04-17 FR FR1565800D patent/FR1565800A/fr not_active Expired
- 1968-04-19 GB GB08659/68A patent/GB1183176A/en not_active Expired
- 1968-04-19 BE BE713975D patent/BE713975A/xx not_active IP Right Cessation
- 1968-04-19 NL NL6805576.A patent/NL162488C/xx not_active IP Right Cessation
- 1968-04-19 AT AT382268A patent/AT285320B/de not_active IP Right Cessation
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3718469A (en) * | 1969-10-17 | 1973-02-27 | Fuji Photo Film Co Ltd | Making of a photographic image |
US4172723A (en) * | 1977-07-20 | 1979-10-30 | De Luxe General, Incorporated | Auxiliary developer processing |
US4269928A (en) * | 1978-02-28 | 1981-05-26 | Ciba-Geigy Aktiengesellschaft | Process for the production of photographic images by dye diffusion transfer and photographic material suitable in this process |
US4243745A (en) * | 1978-05-25 | 1981-01-06 | Ciba-Geigy Ag | Electrolytic production of active diazine species |
US4420551A (en) * | 1983-01-31 | 1983-12-13 | Polaroid Corporation | Novel benzotriazine developers and photographic product and method |
Also Published As
Publication number | Publication date |
---|---|
CH484454A (de) | 1970-01-15 |
NL162488B (nl) | 1979-12-17 |
DE1772123A1 (de) | 1971-02-18 |
GB1183176A (en) | 1970-03-04 |
NL162488C (nl) | 1980-05-16 |
FR1565800A (en:Method) | 1969-05-02 |
BE713975A (en:Method) | 1968-10-21 |
DE1772123C2 (de) | 1982-09-23 |
NL6805576A (en:Method) | 1968-10-21 |
AT285320B (de) | 1970-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4294914A (en) | Photographic bleach compositions and methods of photographic processing | |
GB2140926A (en) | Heat-developable color photographic diffusion transfer material | |
JPS59212829A (ja) | アリ−ルヒドラジド | |
US3635719A (en) | Heat developable light-sensitive elements | |
US3574621A (en) | Process for the development of photographic silver images in acid medium 1,4-diazine | |
US3734738A (en) | Silver halide emulsions containing reactive quaternary salts nucleating agents | |
US3782945A (en) | Mercaptotetrazaindene in photographic printing plate development | |
US3384484A (en) | Silver halide photographic materials containing organic hydrazone compounds | |
US3168400A (en) | Rapid processing of photographic color materials | |
DE2913164C2 (en:Method) | ||
US3716362A (en) | Process for the removal of metallic silver from photographic material | |
US3655382A (en) | Processes for converting zero-valent metals photographic images to formazan dye images | |
US3725068A (en) | Process for the photographic development of silver salts | |
JPH06503183A (ja) | 写真ハロゲン化銀現像処理方法、ハロゲン化銀材料及びそのための溶液 | |
EP0665465A2 (en) | Thermally developable photosensitive element | |
JPS5814672B2 (ja) | 発色現像主薬前駆体を内蔵しているカラ−写真感光材料 | |
US3642482A (en) | Photographic element and process | |
US4242441A (en) | Color image forming process | |
GB2302411A (en) | Silver halide materials | |
US3637388A (en) | Process for the photographic production of equidensities | |
US4472497A (en) | White light handleable photographic materials | |
US4168169A (en) | Dry heat-activated bleaching of silver images | |
GB2061993A (en) | Photographic dyestuffs | |
US3471295A (en) | Production of colored direct-positive images | |
US3565620A (en) | Photographic processing liquids and method of producing photographic images |